drugset / Trial / NCT02522221
Tecarfarin Anti-Coagulation Trial (TACT)
RandomizedParallel-groupOpen-labelTreatment
Summary
TACT is a "real world" randomized controlled trial of tecarfarin, a novel vitamin K antagonist, vs. warfarin. The quality of anticoagulation control will be compared for the two groups of subjects who require chronic oral anticoagulation for a broad panel of indications.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2019-03-30
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tecarfarin | Small molecule | — | Oral |
| Comparator | Warfarin | Small molecule | — | Oral |